In uveal and conjunctival lesions, PRAME overexpression in uveal melanoma correlates with an increased risk of metastasis, while its role in conjunctival melanoma is less clear, but suggests potential as a biomarker. The gene discussed is PRAME; the disease is malignant conjunctival melanoma.